Cost-utility of nintedanib vs. Pirferidone in the treatment of idiopathic pulmonary fibrosis in spain
    
      
    
Abstract
Authors
S Soulard C Crespo
S Soulard C Crespo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now